ACST
Acasti Pharma Inc
Halal Rating :
Last Price
$3.69
Last updated:
Market Cap
-
7D Change
-5.63%
1 Year Change
56.36%
Company Overview
Industries
Exchange
Next Earnings Date
Acasti Pharma Inc is a biopharmaceutical company focused on the research, development, and commercialization of prescription drugs using lipid-based drug delivery technologies. The company is currently developing GTX-104, an intravenous formulation of nimodipine for treating Subarachnoid Hemorrhage, GTX-102, an oral formulation of betamethasone for treating Ataxia Telangiectasia, and GTX-101, a topical spray formulation of celecoxib for treating Postherpetic Neuralgia.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Acasti Pharma Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.